Stock listing
ATHEX:MEDIC Medicon Hellas Μετοχή
Home listing (ATHEX) of Medicon Hellas
Follow Medicon Hellas into a list and get an email when it puts out news.
Share price · ATHEX:MEDIC
€3.09 EUR +0.07 (+2.3%)
Close on Nov 20, 2026
- Day range
- €2.96 – €3.09 EURNov 20, 2026
- Volume
- 58 sharesNov 20, 2026
- Market cap
- €13.66M EURAt the close on Nov 20, 2026 · price × 4.42M shares outstanding
- 52-week range
- €2.32 – €3.22 EURLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- €10,013 EURMedian day 1,579 shares · 4 days with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| ATHEX:MEDIC · Home | €3.09 EUR | +0.07 (+2.3%) | 58 | €3.00 | €3.09 | €2.96 | €3.02 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · ATHEX:MEDIC · EUR, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| €3.09 | +0.07 | +2.3% | €3.00 | €3.09 | €2.96 | 58 | |
| €3.02 | -0.07 | -2.3% | €3.19 | €3.19 | €3.01 | 117 | |
| €3.09 | -0.09 | -2.8% | €3.10 | €3.10 | €3.02 | 2,714 | |
| €3.18 | +0.03 | +1.0% | €3.18 | €3.18 | €3.18 | 10 | |
| €3.15 | 0.00 | 0.0% | €3.15 | €3.18 | €3.15 | 2,500 | |
| €3.15 | 0.00 | 0.0% | €3.15 | €3.15 | €3.15 | 35 | |
| €3.15 | +0.05 | +1.6% | €3.10 | €3.15 | €3.10 | 5,280 | |
| €3.10 | 0.00 | 0.0% | €3.05 | €3.10 | €3.05 | 2,103 | |
| €3.10 | 0.00 | 0.0% | €3.10 | €3.10 | €3.10 | 1,525 | |
| €3.10 | 0.00 | 0.0% | €3.10 | €3.10 | €3.10 | 0 | |
| €3.10 | +0.08 | +2.6% | €3.02 | €3.10 | €3.00 | 2,066 | |
| €3.02 | 0.00 | 0.0% | €3.03 | €3.03 | €2.98 | 3,057 | |
| €3.02 | -0.03 | -1.0% | €3.02 | €3.02 | €3.02 | 2,330 | |
| €3.05 | +0.05 | +1.7% | €3.02 | €3.05 | €3.02 | 2,303 | |
| €3.00 | -0.11 | -3.5% | €3.00 | €3.00 | €3.00 | 1 | |
| €3.11 | 0.00 | 0.0% | €3.11 | €3.11 | €3.11 | 0 | |
| €3.11 | 0.00 | 0.0% | €3.11 | €3.11 | €3.11 | 450 | |
| €3.11 | 0.00 | 0.0% | €3.11 | €3.11 | €3.11 | 213 | |
| €3.11 | +0.02 | +0.6% | €3.10 | €3.11 | €3.09 | 501 | |
| €3.09 | +0.07 | +2.3% | €3.07 | €3.10 | €3.07 | 6,086 | |
| €3.02 | -0.02 | -0.7% | €3.02 | €3.04 | €3.02 | 1,846 | |
| €3.04 | -0.01 | -0.3% | €3.00 | €3.06 | €3.00 | 3,609 | |
| €3.05 | 0.00 | 0.0% | €3.08 | €3.08 | €3.05 | 900 | |
| €3.05 | 0.00 | 0.0% | €3.01 | €3.08 | €3.01 | 738 | |
| €3.05 | -0.03 | -1.0% | €3.00 | €3.10 | €3.00 | 1,579 | |
| €3.08 | 0.00 | 0.0% | €3.02 | €3.08 | €3.02 | 71 | |
| €3.08 | -0.04 | -1.3% | €3.08 | €3.10 | €3.06 | 1,250 | |
| €3.12 | +0.22 | +7.6% | €2.94 | €3.22 | €2.94 | 12,872 | |
| €2.90 | +0.02 | +0.7% | €2.86 | €2.90 | €2.86 | 2,941 | |
| €2.88 | -0.03 | -1.0% | €2.91 | €2.95 | €2.86 | 6,002 | |
| €2.91 | -0.04 | -1.4% | €2.97 | €2.97 | €2.90 | 3,141 | |
| €2.95 | -0.05 | -1.7% | €3.01 | €3.01 | €2.95 | 6,420 | |
| €3.00 | +0.02 | +0.7% | €2.98 | €3.06 | €2.90 | 13,350 | |
| €2.98 | -0.07 | -2.3% | €3.03 | €3.07 | €2.98 | 22,874 | |
| €3.05 | +0.34 | +12.5% | €2.96 | €3.08 | €2.90 | 60,269 | |
| €2.71 | -0.02 | -0.7% | €2.73 | €2.76 | €2.66 | 8,764 | |
| €2.73 | -0.05 | -1.8% | €2.73 | €2.80 | €2.73 | 860 | |
| €2.78 | 0.00 | 0.0% | €2.78 | €2.84 | €2.73 | 2,235 | |
| €2.78 | +0.03 | +1.1% | €2.77 | €2.80 | €2.77 | 580 | |
| €2.75 | -0.01 | -0.4% | €2.75 | €2.75 | €2.70 | 325 | |
| €2.76 | +0.02 | +0.7% | €2.70 | €2.76 | €2.70 | 1,400 | |
| €2.74 | +0.02 | +0.7% | €2.74 | €2.74 | €2.74 | 800 | |
| €2.72 | +0.04 | +1.5% | €2.68 | €2.72 | €2.68 | 1,710 | |
| €2.68 | 0.00 | 0.0% | €2.68 | €2.68 | €2.68 | 0 | |
| €2.68 | -0.08 | -2.9% | €2.67 | €2.70 | €2.66 | 1,632 | |
| €2.76 | +0.07 | +2.6% | €2.76 | €2.76 | €2.76 | 20 | |
| €2.69 | -0.01 | -0.4% | €2.70 | €2.70 | €2.67 | 2,120 | |
| €2.70 | 0.00 | 0.0% | €2.70 | €2.74 | €2.70 | 1,622 | |
| €2.70 | -0.01 | -0.4% | €2.70 | €2.77 | €2.70 | 1,627 | |
| €2.71 | -0.08 | -2.9% | €2.70 | €2.75 | €2.70 | 2,641 | |
| €2.79 | +0.02 | +0.7% | €2.71 | €2.79 | €2.71 | 950 | |
| €2.77 | -0.03 | -1.1% | €2.67 | €2.80 | €2.67 | 3,464 | |
| €2.80 | +0.03 | +1.1% | €2.80 | €2.80 | €2.65 | 1,290 | |
| €2.77 | 0.00 | 0.0% | €2.77 | €2.77 | €2.77 | 0 | |
| €2.77 | +0.01 | +0.4% | €2.72 | €2.77 | €2.66 | 1,830 | |
| €2.76 | -0.02 | -0.7% | €2.78 | €2.78 | €2.76 | 380 | |
| €2.78 | -0.01 | -0.4% | €2.73 | €2.78 | €2.71 | 547 | |
| €2.79 | +0.05 | +1.8% | €2.74 | €2.79 | €2.74 | 210 | |
| €2.74 | +0.01 | +0.4% | €2.79 | €2.79 | €2.74 | 1,305 | |
| €2.73 | 0.00 | 0.0% | €2.78 | €2.82 | €2.73 | 6,445 | |
| €2.73 | +0.05 | +1.9% | €2.65 | €2.73 | €2.64 | 1,990 | |
| €2.68 | -0.05 | -1.8% | €2.73 | €2.73 | €2.68 | 3,337 | |
| €2.73 | -0.01 | -0.4% | €2.61 | €2.75 | €2.61 | 6 | |
| €2.74 | +0.03 | +1.1% | €2.66 | €2.74 | €2.61 | 1,006 | |
| €2.71 | 0.00 | 0.0% | €2.71 | €2.71 | €2.71 | 1,250 |
Splits
2 splits since 2002 · ATHEX:MEDIC · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 11-for-10 | Split | |
| 11-for-10 | Split |
- Ticker
- ATHEX:MEDIC
- Asset type
- Stock
- Sector
- Health care
- Industry
- Diagnostics & research services
- Exchange
- ATHEX
- Currency
- EUR
What changed lately
Latest news release · Jul 1, 2026
Amendment to the 2026 Financial Calendar
Latest news
Amendment to the 2026 Financial Calendar
Jul 1, 2026
Closed €2.98 (-0.3%) on Jul 1, 2026
Announcement 4856/2026
Jun 30, 2026
Closed €2.98 (-0.3%) on Jul 1, 2026
Announcement 4855/2026
Jun 30, 2026
Closed €2.98 (-0.3%) on Jul 1, 2026
Announcement 4854/2026
Jun 30, 2026
Closed €2.98 (-0.3%) on Jul 1, 2026
Amendment of the Financial Calendar
Jun 3, 2026
Closed €2.86 (0.0%) on Jun 4, 2026
Medicon Hellas on 6ix
- Sector
- Health care
- Industry
- Diagnostics & research services
- News releases
- 5 in the last 12 months · 9 in all · newest Jul 1, 2026 · oldest 2024
Where Medicon Hellas is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| ATHEX:MEDIC · Home listing · This page | ATHEX | Greece | EUR |
| LSE:0OKE | LSE | United Kingdom | EUR |
| Lang & Schwarz:677149 | Lang & Schwarz | Germany | EUR |
Valuation
EV/sales 0.4× against a median of 2.2×: 2nd lowest of 11 Diagnostics & research services companies shown. Statements: Year to Dec 31, 2025 · price Nov 20, 2026
- Enterprise value
- €6.98M EUR
- P/E
- 7.7×
- EV/sales
- 0.4×
- EV/EBITDA
- 1.9×
- Price/book
- 0.7×
- Gross margin
- 73.0%
- Operating margin
- 12.6%
- Net margin
- 9.8%
- Debt to equity
- 0.0×
- Beta
- No index for this market yet
Diagnostics & research services: the 10 companies nearest in size, of 302 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Medicon Hellas · ATHEX:MEDIC | US$14.99M | US$7.66M | 7.7× | 0.4× | 1.9× | 0.7× | 9.8% | 0.0× | n/a |
| PlexBio Co., Ltd. · TPEX:6572 | US$15.79M | US$7.19M | n/a | 1.9× | n/a | 1.8× | −49.1% | 0.0× | n/a |
| Biosynex SA · EURONEXT:ALBIO | US$15.37M | US$73.75M | n/a | 0.7× | 2.3× | 0.4× | −61.1% | 1.9× | n/a |
| Verici DX PLC · LSE:VRCI | US$15.25M | US$13.61M | n/a | 3.6× | n/a | 2.6× | −189.2% | 0.1× | n/a |
| Pharmigene, Inc. · TPEX:7595 | US$14.70M | US$29.38M | n/a | 4.8× | n/a | 1.9× | −36.5% | 2.2× | n/a |
| BCAL Diagnostics Limited · ASX:BDX | US$14.64M | US$18.17M | n/a | 150× | n/a | n/a | n/a | n/a | n/a |
| Rhythm Biosciences Limited · ASX:RHY | US$14.05M | US$11.94M | n/a | 211× | n/a | 5.8× | n/a | 0.1× | n/a |
| Noul Co Ltd. · KRX:376930 | US$14.03M | US$6.23M | n/a | 1.6× | n/a | 1.1× | −389.6% | 0.0× | n/a |
| Telescope Innovations Corp · CSE:TELI | US$13.52M | US$12.59M | n/a | 2.5× | n/a | 5.7× | −56.0% | 0.0× | 1.20 |
| LabGenomics Co., Ltd. · KRX:084650 | US$13.28M | US$2.59M | n/a | 0.0× | n/a | 0.1× | −66.5% | 0.1× | n/a |
| IDT Australia Limited · ASX:IDT | US$13.09M | US$18.52M | n/a | 1.4× | n/a | 1.0× | −13.4% | 0.6× | n/a |
| Median of the others | US$14.35M | US$13.10M | 2.2× | 2.3× | 1.8× | −58.6% | 0.1× | 1.20 |
Financials
Annual, in EUR
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 18.0M | 18.1M | 18.1M | 20.8M | 21.5M | 15.3M | 13.4M | 13.8M | 12.7M | 13.0M |
| Cost of revenue | 4.84M | 5.24M | 5.10M | 5.29M | 5.82M | 3.99M | 3.27M | 3.30M | 2.85M | 3.08M |
| Gross profit | 13.1M | 12.9M | 13.0M | 15.5M | 15.7M | 11.3M | 10.2M | 10.5M | 9.85M | 9.93M |
| Research and development | 1.04M | 925.2K | 921.9K | 765.4K | 911.6K | 670.0K | 514.1K | 341.3K | ||
| Selling, general and administrative | 9.49M | 8.54M | 7.49M | 7.30M | 7.07M | 6.95M | 6.62M | |||
| Operating income | 2.26M | 1.64M | 1.81M | 3.83M | 5.00M | 1.59M | 1.11M | 2.18M | 1.95M | 2.89M |
| Depreciation and amortization | 1.51M | 1.75M | 1.70M | 1.63M | 1.69M | 1.41M | 1.17M | 622.9K | 647.6K | 646.8K |
| EBITDA | 3.77M | 3.39M | 3.51M | 5.47M | 6.69M | 3.00M | 2.28M | 2.80M | 2.59M | 3.53M |
| Interest expense | 457.5K | 638.0K | 888.3K | 331.5K | 352.3K | 0 | 0 | 0 | 0 | 0 |
| Income before tax | 2.07M | 1.55M | 1.67M | 3.66M | 4.78M | 1.45M | 1.53M | 3.60M | 2.30M | 1.48M |
| Income tax | 302.8K | 185.2K | 273.2K | 955.6K | 1.54M | 634.6K | 681.7K | 1.70M | 553.2K | 267.6K |
| Net income | 1.77M | 1.33M | 1.32M | 2.53M | 3.04M | 756.6K | 775.2K | 1.83M | 1.72M | 1.17M |
| Earnings per share, basic | 0.39 | 0.29 | 0.30 | 0.57 | 0.69 | 0.17 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 6.68M | 8.51M | 5.46M | 10.2M | 10.4M | 7.20M | 6.07M | 6.22M | 4.42M | 4.04M |
| Receivables | 7.25M | 8.61M | 9.24M | 8.26M | 7.52M | 6.59M | 7.40M | 7.81M | 10.9M | 12.2M |
| Inventory | 3.51M | 2.86M | 3.29M | 2.77M | 2.61M | 3.42M | 3.24M | 2.99M | 2.64M | 2.63M |
| Current assets | 22.7M | 21.7M | 21.9M | 22.4M | 21.1M | 17.7M | 17.3M | 17.6M | 18.7M | 20.0M |
| Property, plant and equipment | 7.29M | 7.00M | 7.24M | 6.69M | 7.24M | 7.82M | 7.40M | 5.43M | 5.27M | 4.92M |
| Total assets | 32.7M | 31.5M | 32.0M | 31.8M | 31.2M | 28.6M | 28.5M | 27.2M | 30.7M | 33.0M |
| Accounts payable | 2.97M | 2.78M | 2.84M | 2.53M | 2.47M | 1.38M | 711.1K | 719.3K | 1.53M | 1.46M |
| Current liabilities | 4.38M | 3.95M | 4.17M | 3.69M | 4.74M | 3.91M | 3.10M | 2.81M | 21.6M | 25.9M |
| Long-term debt | 9.90M | 10.7M | 11.6M | 12.8M | 13.5M | |||||
| Total debt | 12.6M | 13.8M | 13.5M | |||||||
| Total liabilities | 14.9M | 16.8M | 17.6M | 18.3M | 17.5M | 22.8M | 26.9M | |||
| Shareholders' equity | 19.8M | 18.6M | 17.7M | 17.5M | 14.9M | 11.0M | 10.3M | 9.68M | 7.84M | 6.12M |
| Shares outstanding | 4.42M | 4.42M | 4.42M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 4.41M | 2.00M | 878.3K | 1.25M | 4.79M | 3.07M | 1.62M | 3.19M | 4.84M | 1.84M |
| Capital spending | -1.50M | -1.01M | -1.59M | -407.7K | -554.3K | -734.5K | -1.89M | -598.5K | -134.9K | -92.4K |
| Free cash flow | 2.91M | 995.4K | -716.5K | 840.7K | 4.24M | 2.34M | -267.8K | 2.59M | 4.70M | 1.75M |
| Cash from investing | -1.32M | -398.2K | -984.2K | -214.9K | -315.5K | -495.2K | -1.54M | 3.35M | 460.3K | 226.3K |
| Cash from financing | -925.3K | -1.55M | -1.64M | -1.18M | -1.32M | -1.45M | -227.8K | -4.74M | -4.91M | -421.9K |
| Dividends paid | -574.6K | -265.2K | -1.27M | -106.4K | -114.3K | -114.3K | -114.3K | -114.3K | ||
| Change in cash | 2.16M | 47.9K | -1.75M | -147.7K | 3.16M | 1.13M | -151.3K | 1.80M | 389.1K | 1.64M |
Cap table
Built by 6ix from Medicon Hellas’ releases
- Common shares
- 4,419,616
- Fully diluted
- 4,419,616
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 4,419,616 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 4,419,616 |
Log in to ask 6ix AI your own questions about Medicon Hellas.